| JYHB2002628 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-12-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Filed | 2020-12-29 | view |
| JYHB2300044 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2023-01-13 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB1800247 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2018-03-12 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Viiv Healthcare Uk Ltd | Certificate Issued | 2019-07-01 | view |
| CYHS2404620 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2024-12-31 | | Shijiazhuang Lonzeal Pharmaceuticals Co Ltd | | | view |
| JYHZ2000175 | 多替拉韦钠片 | | Tablet | Chemical Drugs | License Renew | 2020-07-11 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Certificate Issued | 2020-12-22 | view |
| JYHB2101115 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2021-05-26 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JXHL1400107 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Import Drug Application | 2014-04-17 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare Uk Ltd | Certificate Issued | 2015-03-27 | view |
| JYHS2400014 | 多替拉韦钠片 | | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2024-04-02 | | Hetero Labs Ltd;Hetero Phrma (Beijing) Co Limited | | | view |
| JYHB2000102 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-03-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Certificate Issued | 2020-06-19 | view |
| CYHS2501437 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2025-04-15 | | NORTHEAST Pharmaceutical Group Shenyang NO1 Pharmaceutical Co Ltd | | | view |
| JYHB2300045 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2023-01-13 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB1600799 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2016-06-22 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Viiv Healthcare Uk Ltd | Certificate Issued | 2017-01-04 | view |
| CYHS2404038 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2024-11-23 | | Jiangsu Aidea Pharmaceutical Co Ltd | | | view |
| JYHB2000691 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-07-06 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;GlaxoSmithKline Phaemaceuticals SA | Certificate Issued | 2021-11-12 | view |
| CYHS2501764 | 多替拉韦钠片 | | Tablet | Chemical Drugs(4) | Generic Drug | 2025-05-15 | | Anhui Biochem Bio-Pharmaceutical Co Ltd | | | view |
| JYHB2101107 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2021-05-20 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2400126 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2024-03-15 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JTH1800206 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Disposable Import Drug Application | 2018-06-20 | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | Glaxo Operations UK Ltd;GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare Uk Ltd | Certificate Issued | 2018-07-10 | view |
| JYHB2500083 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2025-02-20 | | Viiv Healthcare BV;Glaxo Operations UK Ltd | | | view |
| JYHB2001841 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-09-22 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;Glaxo Operations UK Ltd | Filed | 2020-10-12 | view |
